Navigation Links
QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System
Date:10/28/2008


Sustained release treatment leads to reduction in IOP of 20% from

baseline at 12 weeks

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced data from its CORE study, a Phase II trial being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. (QPD), to evaluate the safety and efficacy of its Latanoprost Punctal Plug Delivery System (L-PPDS) for the treatment of open angle glaucoma (OAG) and ocular hypertension (OH). Sixty-one patients were enrolled in the study and 23 patients discontinued before the Week-12 visit due to either loss of efficacy/inadequate IOP control (19 patients) or loss of L-PPDS in both eyes (four patients). The mean change in intraocular pressure (IOP) from baseline at 12 weeks among patients who completed the study was -5.4 mmHg, -4.8 mmHg and -4.9 mmHg for the low, medium, and high concentrations of latanoprost respectively. This represents a clinically meaningful reduction of 20% from baseline at the 12-week time point in those patients. The L-PPDS were well tolerated during the course of treatment.

"We are pleased to report the results from our proof-of-concept Phase II CORE study, which showed a reduction in IOP that is within the acceptable range for physicians treating patients with glaucoma," said Bob Butchofsky, President and Chief Executive Officer of QLT. "This data confirms the viability of the approach we have pioneered, of employing punctal plugs as a non-invasive method of delivering already approved drugs to the eye. We plan to continue to investigate additional doses to see if efficacy may be further enhanced."

"The Latanoprost Punctal Plug Delivery System represents one of the most exciting exploratory programs addressing the unmet medical need of poor compliance and adherence patterns to treatment regimens seen in glaucoma and ocular hypertensive patients," said Lou Cantor, MD, Director, Glaucoma Service, I
'/>"/>

SOURCE QLT Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Response Biomedical Announces Insider Participation in Current Financing
2. American National Announces Third Quarter 2008 Results
3. Digestive Care, Inc. Announces the Complete Submission of the NDA for PANCRECARB(R) (pancrelipase)
4. U.S. Preventive Medicine(R) Announces Major Development for The Prevention Plan(TM)
5. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
6. HLTH Corporation Announces Commencement of Its Tender Offer
7. ReachMD XM 157 Announces Medical Information Feature on Treatment Options for Management of Hyponatremia
8. Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908
9. UCSF Chancellor J. Michael Bishop Announces Plan To Step Down
10. USC Cancer Center Announces Contribution By Larry and Judy Freeman
11. Sikorsky Aircraft Announces Contract with Boston MedFlight for S-76C++(TM) Helicopter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Researchers at Le Bonheur Children,s Hospital and the ... a clinical trial of a new drug shown to ... healthy adult volunteers intranasally infected with respiratory syncytial virus ... respiratory tract infections in young children in the United ... the labs of Infectious Disease Specialist John DeVincenzo, MD. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Memantine was initially ... first marketed in Germany under the brand name Akatinol; it ... nations as Ebixa and in the USA to Forest Labs ... 420 million in 2013. In the US, Forest reported Namenda ... protection expiry in Canada, Australia and the European region has ...
(Date:7/24/2014)... 24, 2014 As the age of ... egg freezing as a way to ensure future family ... decline with advancing reproductive age. Vitrification technology, a fast ... edge medical technology that allows a woman to have ... fertility years, which are then stored for future use. ...
(Date:7/24/2014)... scientists at Carnegie Mellon University, working with high-throughput ... Berkeley National Laboratory, have devised a computational method ... normal breast cells turn malignant and as they ... for analyzing how genes interact with each other ... published today by the online journal PLOS ...
(Date:7/24/2014)... In a recent report by CBS News, the ... end to criminal penalties associated with possession of small amounts ... reform in Washington DC, giving it one of the most ... penalties for possession of one ounce of marijuana or less ... more than an ounce of marijuana remain criminal offenses under ...
Breaking Medicine News(10 mins):Health News:RSV research breakthrough to help infected children 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2
... Steven Reinberg HealthDay Reporter , THURSDAY, Nov. ... medications can help people with heart disease live ... according to new guidelines from the American College of ... Following the updated recommendations can also improve quality of ...
... have found important new relationships between obesity, sleep-disordered ... children. "The intricate interdependencies between BMI, ... of particular importance in children, as their brains ... Spruyt, PhD, assistant professor in the Department of ...
... Nancy Grace and her partner danced a lively rumba to Spandau ... more was going on in the legal commentator,s brain than worry ... millions of neurons were hard at work doing what they apparently ... MacManus,s movements to create a pas de deux that had the ...
... , THURSDAY, Nov. 3 (HealthDay News) -- Smokers are more ... area of their brain that processes emotions was damaged by ... people who planned to stop smoking before they had a ... than those who hadn,t thought about quitting. These findings ...
... has long been known that cancer cells use nutrients differently ... field of cancer metabolism has shed new light on the ... demonstrating that manipulation of an enzyme called PKM2 is important ... by a scientific team at Beth Israel Deaconess Medical Center ...
... to stay awake. Very bright light not only arouses us ... can make us sleepy. It,s the reason some people use ... sleep. Now researchers at UCLA have identified ... or not. Jerome Siegel, a professor of psychiatry at ...
Cached Medicine News:Health News:Rx for Heart Patients: Healthier Living, Medication 2Health News:Rx for Heart Patients: Healthier Living, Medication 3Health News:Body weight, sleep-disordered breathing and cognition linked in children 2Health News:It takes two: Brains come wired for cooperation, neuroscientist asserts 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 2Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 3Health News:UCLA researchers identify brain cells responsible for keeping us awake 2
(Date:7/24/2014)... July 24, 2014  Abaxis, Inc. (NasdaqGS: ... analysis systems, today reported financial results for the first ... quarter overview: , Revenues of $47.5 million, up ... EPS of $0.21, up 50% over last year,s comparable ... revenues of $7.2 million, up 20% over last year,s ...
(Date:7/24/2014)... 2014  IRIDEX Corporation (NASDAQ: IRIX ) ... 2014 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, July 31, 2014 to ... developments. Interested parties may access the live ...
(Date:7/24/2014)... , July 24, 2014 Omnicell, Inc. ... of medication and supply management solutions and analytics ... Thursday, July 31, to discuss the Company,s Second ... Second Quarter 2014 earnings conference call and webcastWhen: ... , Randall Lipps, chairman, president and chief executive ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... 2011 AccuVein LLC announced today that the United States ... for its vascular illumination technology and that a second patent ... additional patents pending in the United States and around the ... President and CEO of AccuVein. "Our technology team has built ...
... Delcath Systems, Inc. (NASDAQ: DCTH ) today ... Mark approval for its proprietary Hepatic CHEMOSAT™ Delivery System. ... the percutaneous intra-arterial administration of a chemotherapeutic agent (melphalan ... that a medical device complies with the Essential Requirements ...
Cached Medicine Technology:Award Winning Vascular Imaging Device Company Announces New Patents 2Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System 2Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System 3
New!...
... Electrical I/A unit for planned ... aspiration (foot control). Independent irrigation, suction, ... allows the surgeon to control all ... all functions simultaneously. Preset and actual ...
... Anterior and Posterior segment surgeries Vitrectomy-Lensectomy ... Ventury or Peristaltic Linear Aspiration. Interchangeable ... specific cutting action. Easy to read ... Cutting speed-variable from 1- 600 cuts ...
...
Medicine Products: